Predictive glycoengineering of biosimilars using a Markov chain glycosylation model
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Predictive glycoengineering of biosimilars using a Markov chain glycosylation model
Authors
Keywords
-
Journal
Biotechnology Journal
Volume 12, Issue 2, Pages 1600489
Publisher
Wiley
Online
2016-11-17
DOI
10.1002/biot.201600489
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Orphan Drug Act
- (2016) Michael G. Daniel et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Dynamics of immature mAb glycoform secretion during CHO cell culture: An integrated modelling framework
- (2016) Ioscani Jimenez del Val et al. Biotechnology Journal
- Controlling the time evolution of mAb N-linked glycosylation - Part II: Model-based predictions
- (2016) Thomas K. Villiger et al. BIOTECHNOLOGY PROGRESS
- Modulating carbohydrate–protein interactions through glycoengineering of monoclonal antibodies to impact cancer physiology
- (2016) Austin WT Chiang et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Challenges of glycosylation analysis and control: an integrated approach to producing optimal and consistent therapeutic drugs
- (2016) Peiqing Zhang et al. DRUG DISCOVERY TODAY
- A Markov chain model for N-linked protein glycosylation – towards a low-parameter tool for model-driven glycoengineering
- (2016) Philipp N. Spahn et al. METABOLIC ENGINEERING
- Dynamics of immature mAb glycoform secretion during CHO cell culture: An integrated modelling framework
- (2016) Ioscani Jimenez del Val et al. Biotechnology Journal
- Monensin, a small molecule ionophore, can be used to increase high mannose levels on monoclonal antibodies generated by Chinese hamster ovary production cell-lines
- (2015) Sandhya Pande et al. BIOTECHNOLOGY AND BIOENGINEERING
- Low glucose depletes glycan precursors, reduces site occupancy and galactosylation of a monoclonal antibody in CHO cell culture
- (2015) Carina Villacrés et al. Biotechnology Journal
- One-step generation of triple knockout CHO cell lines using CRISPR/Cas9 and fluorescent enrichment
- (2015) Lise Marie Grav et al. Biotechnology Journal
- CRISPR/Cas9-mediated genome engineering of CHO cell factories: Application and perspectives
- (2015) Jae Seong Lee et al. Biotechnology Journal
- Tailoring recombinant protein quality by rational media design
- (2015) David Brühlmann et al. BIOTECHNOLOGY PROGRESS
- Chinese hamster ovary (CHO) host cell engineering to increase sialylation of recombinant therapeutic proteins by modulating sialyltransferase expression
- (2015) Nan Lin et al. BIOTECHNOLOGY PROGRESS
- Biosimilars advancements: Moving on to the future
- (2015) Lilian Rumi Tsuruta et al. BIOTECHNOLOGY PROGRESS
- Engineering Complex Synthetic Transcriptional Programs with CRISPR RNA Scaffolds
- (2015) Jesse G. Zalatan et al. CELL
- The Current Status and Prospects of Antibody Engineering for Therapeutic Use: Focus on Glycoengineering Technology
- (2015) Rinpei Niwa et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Immunology: Magic bullets to blockbusters
- (2015) Marian Turner NATURE
- Engineered CHO cells for production of diverse, homogeneous glycoproteins
- (2015) Zhang Yang et al. NATURE BIOTECHNOLOGY
- Low glucose depletes glycan precursors, reduces site occupancy and galactosylation of a monoclonal antibody in CHO cell culture
- (2015) Carina Villacrés et al. Biotechnology Journal
- One-step generation of triple knockout CHO cell lines using CRISPR/Cas9 and fluorescent enrichment
- (2015) Lise Marie Grav et al. Biotechnology Journal
- CRISPR/Cas9-mediated genome engineering of CHO cell factories: Application and perspectives
- (2015) Jae Seong Lee et al. Biotechnology Journal
- Identification of manipulated variables for a glycosylation control strategy
- (2014) Melissa M. St. Amand et al. BIOTECHNOLOGY AND BIOENGINEERING
- Manganese increases high mannose glycoform on monoclonal antibody expressed in CHO when glucose is absent or limiting: Implications for use of alternate sugars
- (2014) Tanaya Surve et al. BIOTECHNOLOGY PROGRESS
- Systems glycobiology for glycoengineering
- (2014) Philipp N Spahn et al. CURRENT OPINION IN BIOTECHNOLOGY
- Towards Controlling the Glycoform: A Model Framework Linking Extracellular Metabolites to Antibody Glycosylation
- (2014) Philip Jedrzejewski et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A guide to genome engineering with programmable nucleases
- (2014) Hyongbum Kim et al. NATURE REVIEWS GENETICS
- Emerging Principles for the Therapeutic Exploitation of Glycosylation
- (2014) Martin Dalziel et al. SCIENCE
- Metabolic Engineering of Monoclonal Antibody Carbohydrates for Antibody–Drug Conjugation
- (2013) Nicole M. Okeley et al. BIOCONJUGATE CHEMISTRY
- Physicochemical and Functional Comparability Between the Proposed Biosimilar Rituximab GP2013 and Originator Rituximab
- (2013) Jan Visser et al. BIODRUGS
- CHO cell line specific prediction and control of recombinant monoclonal antibodyN-glycosylation
- (2013) Rhian K. Grainger et al. BIOTECHNOLOGY AND BIOENGINEERING
- RNA-guided gene activation by CRISPR-Cas9–based transcription factors
- (2013) Pablo Perez-Pinera et al. NATURE METHODS
- ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering
- (2013) Thomas Gaj et al. TRENDS IN BIOTECHNOLOGY
- Global metabolic inhibitors of sialyl- and fucosyltransferases remodel the glycome
- (2012) Cory D Rillahan et al. Nature Chemical Biology
- Modulation of antibody galactosylation through feeding of uridine, manganese chloride, and galactose
- (2011) Michael J. Gramer et al. BIOTECHNOLOGY AND BIOENGINEERING
- Systems glycobiology: biochemical reaction networks regulating glycan structure and function
- (2011) S. Neelamegham et al. GLYCOBIOLOGY
- Glycosylation of Therapeutic Proteins
- (2010) Ricardo J. Solá et al. BIODRUGS
- Pharmacological significance of glycosylation in therapeutic proteins
- (2009) Huijuan Li et al. CURRENT OPINION IN BIOTECHNOLOGY
- Glycosylation as a strategy to improve antibody-based therapeutics
- (2009) Roy Jefferis NATURE REVIEWS DRUG DISCOVERY
- Terminal sugars of Fc glycans influence antibody effector functions of IgGs
- (2008) T Shantha Raju CURRENT OPINION IN IMMUNOLOGY
- Effects of glycosylation on the stability of protein pharmaceuticals
- (2008) Ricardo J. Solá et al. JOURNAL OF PHARMACEUTICAL SCIENCES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More